Pharmaceutical companíe enjoy great results in 2020 despite COVID-19

Social distancing and strict control at hospitals, and an economic recession due to COVID-19, resulted in lower sales of both prescription and non-prescription drugs. However, many companies still witnessed outstanding performance.

In the fourth quarter financial results, Central Pharmaceutical JSC No3 (DP3) reported a gain of 8% year-on-year in net revenue, but its profit after tax was 11.6 times higher than that in 2019 to VND38.2 billion.

The good result was due to a strong increase in financial activities income (up 15.2 times), and a decrease in interest expenses (down 20.7%) and other expenses (down nearly 70%).

Last year, the company’s profit after tax was VND114.05 billion, 13 times higher than that of 2019.

Imexpharm Corporation (IMP)’s net revenue in the last quarter of 2020 dropped 5.6% year-on-year to VND478 billion. But a decline in costs of goods sold (nearly 12%), general and administrative expenses (52.4%) and other expenses (70.5%) helped its profit after tax rise against the same period of 2019.

Imexpharm saw an increase of 35.3% in profit after tax in the fourth quarter of last year to nearly VND70.4 billion. For the whole of 2020, its profit after tax rose over 29% to VND209.7 billion.

Another drug company seeing good performance last year was Traphaco JSC (TRA). In the fourth quarter, Traphaco posted a rise of 11.6% in revenue to over VND602 billion. Its profit after tax increased by 20.1% to VND75.3 billion in the same period.

In 2020, the company’s profit after tax climbed nearly 27.2% to VND216.75 billion.

Similarly, DHG Pharmaceutical JSC (DHG)’s profit after tax increased by 2.76% year-on-year to VND209.5 billion in the last quarter of 2020. Its profit after tax also rose slightly by 1.2% to VND738.5 billion in 2020.

Even though seeing a decrease of 11.3% in the last quarter last year, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD)'s profit after tax still posted a gain of 14.4% for the whole year.

Mời quý độc giả theo dõi VOV.VN trên
Viết bình luận

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.